American Century Companies’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Buy |
169,168
+18,292
| +12% | +$205K | ﹤0.01% | 2047 |
|
|
2025
Q1 | $690K | Buy |
150,876
+23,412
| +18% | +$107K | ﹤0.01% | 2389 |
|
|
2024
Q4 | $719K | Buy |
127,464
+13,916
| +12% | +$78.5K | ﹤0.01% | 2377 |
|
|
2024
Q3 | $550K | Buy |
113,548
+21,048
| +23% | +$102K | ﹤0.01% | 2447 |
|
|
2024
Q2 | $451K | Buy |
92,500
+16,525
| +22% | +$80.6K | ﹤0.01% | 2480 |
|
|
2024
Q1 | $1.01M | Buy |
75,975
+29,848
| +65% | +$396K | ﹤0.01% | 2149 |
|
|
2023
Q4 | $643K | Buy |
46,127
+19,297
| +72% | +$269K | ﹤0.01% | 2267 |
|
|
2023
Q3 | $356K | Buy |
26,830
+8,680
| +48% | +$115K | ﹤0.01% | 2399 |
|
|
2023
Q2 | $340K | Buy |
+18,150
| New | +$340K | ﹤0.01% | 2358 |
|